PRENA1 TRUE Rx
Generic Name and Formulations:
Vit.C 60mg, Vit.D2 600 IU, Vit.E 30 IU, Vit.B1 3mg, Vit.B2 3.4mg, Vit.B3 20mg, Vit.B6 25mg, folic acid (as Folmax) 1.4mg, Vit.B12 12mcg, biotin 300mcg, pantothenic acid 10mg, calcium (as carbonate) 150mg, iron (as amino acid chelate) 30mg, iodine (as potassium iodide) 150mcg, zinc (as amino acid chelate) 15mg, copper (as amino acid chelate) 2mg; per tab. DHA (docosahexaenoic acid [algal oil]) 300mg; per softgel.
Indications for PRENA1 TRUE:
As a dietary supplement for pregnant and nursing women.
Take 1 tab and 1 softgel daily with a meal.
Folic acid may mask pernicious anemia. Bleeding diatheses.
Iron, calcium block tetracycline absorption. Antagonizes levodopa. Avoid anticoagulants.
True—60 (30 tabs + 30 softgels)
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies